Spero Therapeutics Inc (SPRO): Next-Year EPS Estimate 331.03%
As of 2026-06-22, Spero Therapeutics Inc (SPRO) has a next-year EPS growth estimate of 331.03%.
On 2026-06-21, analyst consensus for SPRO's next-year EPS growth shifted from 770.00% to 331.03% — a negative change of 438.97 percentage points. The revised estimate has been sustained across 2 subsequent trading sessions. Current-year growth is projected at -293.33%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 331.03%
- EPS growth this year
- -293.33%
- EPS next quarter (est)
- N/A
- Last price
- $2.26
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-22 | 331.03% | -293.33% | N/A | $2.26 |
| 2026-06-21 | 331.03% | -293.33% | N/A | $2.28 |
| 2026-03-26 | 770.00% | N/A | N/A | $2.37 |
| 2026-03-26 | 770.00% | N/A | N/A | $2.37 |
| 2026-03-26 | 770.00% | N/A | N/A | $2.37 |
| 2026-03-25 | 770.00% | N/A | N/A | $2.41 |
| 2026-03-25 | 770.00% | N/A | N/A | $2.41 |
| 2026-03-25 | 770.00% | N/A | N/A | $2.41 |
| 2026-03-24 | 770.00% | N/A | N/A | $2.37 |
| 2026-03-24 | 770.00% | N/A | N/A | $2.37 |
| 2026-03-24 | 770.00% | N/A | N/A | $2.37 |
| 2026-03-23 | 770.00% | N/A | N/A | $2.35 |
| 2026-03-20 | 770.00% | N/A | N/A | $2.37 |
| 2026-03-19 | 770.00% | N/A | N/A | $2.47 |
| 2026-03-18 | 770.00% | N/A | N/A | $2.46 |
| 2026-03-17 | 770.00% | N/A | N/A | $2.58 |
Recent News
Screen Performance
Aggregate stats across all 1803 tickers our top-EPS-revision screen has flagged over the past 82 days.
- Median return since detection
- +3.2%
- % of tickers in the green
- 57%
- Median return on winners
- +19.6%
- Large revisions captured
- 859
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Spero Therapeutics Inc's next-year EPS growth estimate?▾
As of 2026-06-22, Spero Therapeutics Inc (SPRO) has a next-year EPS growth estimate of 331.03%, based on analyst consensus.
When was the latest EPS estimate revision for SPRO?▾
The most recent revision occurred on 2026-06-21, when analysts adjusted the next-year EPS growth estimate from 770.00% to 331.03%.
What sector and industry does Spero Therapeutics Inc belong to?▾
Spero Therapeutics Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. SPRO appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Spero Therapeutics Inc (SPRO) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports